Annual CFO:
-$8.31M-$112.47M(-107.98%)Summary
- As of today, ALNY annual cash from operations is -$8.31 million, with the most recent change of -$112.47 million (-107.98%) on December 31, 2024.
- During the last 3 years, ALNY annual cash from operations has risen by +$633.38 million (+98.70%).
- ALNY annual cash from operations is now -104.23% below its all-time high of $196.52 million, reached on December 31, 2007.
Performance
ALNY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$153.73M+$272.04M(+229.93%)Summary
- As of today, ALNY quarterly cash from operations is $153.73 million, with the most recent change of +$272.04 million (+229.93%) on June 30, 2025.
- Over the past year, ALNY quarterly cash from operations has increased by +$29.57 million (+23.82%).
- ALNY quarterly cash from operations is now -57.23% below its all-time high of $359.41 million, reached on September 30, 2023.
Performance
ALNY Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$15.54M+$29.57M(+65.55%)Summary
- As of today, ALNY TTM cash from operations is -$15.54 million, with the most recent change of +$29.57 million (+65.55%) on June 30, 2025.
- Over the past year, ALNY TTM cash from operations has dropped by -$387.80 million (-104.17%).
- ALNY TTM cash from operations is now -104.17% below its all-time high of $372.26 million, reached on June 30, 2024.
Performance
ALNY TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALNY Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -108.0% | +23.8% | -104.2% |
| 3Y3 Years | +98.7% | +225.2% | +97.3% |
| 5Y5 Years | +97.0% | +213.6% | +97.7% |
ALNY Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -108.0% | +98.7% | -57.2% | +192.3% | -104.2% | +97.2% |
| 5Y | 5-Year | -108.0% | +98.7% | -57.2% | +165.2% | -104.2% | +97.7% |
| All-Time | All-Time | -104.2% | +98.7% | -57.2% | +162.4% | -104.2% | +98.0% |
ALNY Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $153.73M(+229.9%) | -$15.54M(+65.6%) |
| Mar 2025 | - | -$118.31M(-25.0%) | -$45.11M(-442.7%) |
| Dec 2024 | -$8.31M(-108.0%) | -$94.66M(-316.6%) | -$8.31M(-114.7%) |
| Sep 2024 | - | $43.71M(-64.8%) | $56.55M(-84.8%) |
| Jun 2024 | - | $124.16M(+252.3%) | $372.26M(+96.8%) |
| Mar 2024 | - | -$81.52M(-173.6%) | $189.12M(+81.6%) |
| Dec 2023 | $104.16M(+119.2%) | -$29.80M(-108.3%) | $104.16M(+5179.1%) |
| Sep 2023 | - | $359.41M(+709.3%) | $1.97M(+100.4%) |
| Jun 2023 | - | -$58.99M(+64.6%) | -$472.72M(+11.9%) |
| Mar 2023 | - | -$166.47M(-26.1%) | -$536.56M(+0.9%) |
| Dec 2022 | -$541.27M(+15.6%) | -$131.98M(-14.5%) | -$541.27M(+3.2%) |
| Sep 2022 | - | -$115.28M(+6.1%) | -$559.44M(+3.2%) |
| Jun 2022 | - | -$122.82M(+28.3%) | -$578.19M(-0.2%) |
| Mar 2022 | - | -$171.19M(-14.0%) | -$577.23M(+10.0%) |
| Dec 2021 | -$641.69M(-4.3%) | -$150.14M(-12.0%) | -$641.69M(-4.4%) |
| Sep 2021 | - | -$134.04M(-10.0%) | -$614.70M(-4.0%) |
| Jun 2021 | - | -$121.86M(+48.3%) | -$590.99M(+2.2%) |
| Mar 2021 | - | -$235.66M(-91.4%) | -$604.46M(+1.7%) |
| Dec 2020 | -$614.96M(-120.9%) | -$123.14M(-11.6%) | -$614.96M(+10.6%) |
| Sep 2020 | - | -$110.33M(+18.5%) | -$687.80M(+9.5%) |
| Jun 2020 | - | -$135.33M(+45.0%) | -$760.10M(-126.2%) |
| Mar 2020 | - | -$246.16M(-25.6%) | -$336.08M(-20.7%) |
| Dec 2019 | -$278.43M(+50.5%) | -$195.98M(-7.3%) | -$278.43M(-19.5%) |
| Sep 2019 | - | -$182.63M(-163.3%) | -$232.90M(-14.1%) |
| Jun 2019 | - | $288.69M(+253.1%) | -$204.08M(+65.7%) |
| Mar 2019 | - | -$188.51M(-25.3%) | -$595.46M(-5.8%) |
| Dec 2018 | -$562.62M(-47.0%) | -$150.46M(+2.2%) | -$562.62M(-9.2%) |
| Sep 2018 | - | -$153.81M(-49.8%) | -$515.20M(-12.1%) |
| Jun 2018 | - | -$102.69M(+34.0%) | -$459.76M(-4.9%) |
| Mar 2018 | - | -$155.66M(-51.1%) | -$438.12M(-14.5%) |
| Dec 2017 | -$382.79M(-24.4%) | -$103.04M(-4.8%) | -$382.79M(-6.9%) |
| Sep 2017 | - | -$98.36M(-21.4%) | -$358.08M(-6.8%) |
| Jun 2017 | - | -$81.05M(+19.2%) | -$335.25M(-3.3%) |
| Mar 2017 | - | -$100.33M(-28.1%) | -$324.41M(-5.4%) |
| Dec 2016 | -$307.70M(-62.7%) | -$78.34M(-3.7%) | -$307.70M(-8.9%) |
| Sep 2016 | - | -$75.54M(-7.6%) | -$282.43M(-8.1%) |
| Jun 2016 | - | -$70.20M(+16.0%) | -$261.26M(-6.0%) |
| Mar 2016 | - | -$83.62M(-57.6%) | -$246.51M(-30.3%) |
| Dec 2015 | -$189.14M(-14.2%) | -$53.06M(+2.4%) | -$189.14M(-9.5%) |
| Sep 2015 | - | -$54.37M(+2.0%) | -$172.71M(-8.6%) |
| Jun 2015 | - | -$55.46M(-111.2%) | -$159.05M(-5.9%) |
| Mar 2015 | - | -$26.25M(+28.3%) | -$150.22M(+9.3%) |
| Dec 2014 | -$165.64M | -$36.63M(+10.0%) | -$165.64M(-9.4%) |
| Sep 2014 | - | -$40.71M(+12.7%) | -$151.38M(-14.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$46.63M(-11.9%) | -$132.38M(-21.1%) |
| Mar 2014 | - | -$41.67M(-86.3%) | -$109.36M(-59.3%) |
| Dec 2013 | -$68.66M(+40.6%) | -$22.37M(-3.0%) | -$68.66M(+40.4%) |
| Sep 2013 | - | -$21.71M(+8.0%) | -$115.20M(-30.5%) |
| Jun 2013 | - | -$23.60M(-2330.7%) | -$88.27M(-2.2%) |
| Mar 2013 | - | -$971.00K(+98.6%) | -$86.36M(+25.3%) |
| Dec 2012 | -$115.61M(-32.8%) | -$68.91M(-1422.2%) | -$115.61M(-60.9%) |
| Sep 2012 | - | $5.21M(+124.0%) | -$71.86M(+32.3%) |
| Jun 2012 | - | -$21.69M(+28.2%) | -$106.09M(+4.4%) |
| Mar 2012 | - | -$30.21M(-20.1%) | -$110.98M(-27.5%) |
| Dec 2011 | -$87.07M(-3.2%) | -$25.16M(+13.3%) | -$87.07M(-5.8%) |
| Sep 2011 | - | -$29.02M(-9.2%) | -$82.30M(-6.5%) |
| Jun 2011 | - | -$26.58M(-321.6%) | -$77.31M(-3.0%) |
| Mar 2011 | - | -$6.30M(+69.1%) | -$75.05M(+11.0%) |
| Dec 2010 | -$84.34M(-16.9%) | -$20.39M(+15.2%) | -$84.34M(-4.4%) |
| Sep 2010 | - | -$24.04M(+1.1%) | -$80.82M(-4.5%) |
| Jun 2010 | - | -$24.31M(-55.8%) | -$77.37M(+13.0%) |
| Mar 2010 | - | -$15.60M(+7.5%) | -$88.98M(-23.3%) |
| Dec 2009 | -$72.14M(-210.2%) | -$16.87M(+18.1%) | -$72.14M(-20.0%) |
| Sep 2009 | - | -$20.59M(+42.7%) | -$60.13M(-8.2%) |
| Jun 2009 | - | -$35.92M(-3017.9%) | -$55.55M(-173.7%) |
| Mar 2009 | - | $1.23M(+125.4%) | $75.38M(+15.1%) |
| Dec 2008 | $65.49M(-66.7%) | -$4.85M(+69.7%) | $65.49M(+5.8%) |
| Sep 2008 | - | -$16.01M(-116.9%) | $61.90M(-79.5%) |
| Jun 2008 | - | $95.01M(+1197.3%) | $302.22M(+52.0%) |
| Mar 2008 | - | -$8.66M(-2.6%) | $198.82M(+1.2%) |
| Dec 2007 | $196.52M(+897.9%) | -$8.44M(-103.8%) | $196.52M(-1.9%) |
| Sep 2007 | - | $224.31M(+2773.2%) | $200.34M(+844.9%) |
| Jun 2007 | - | -$8.39M(+23.4%) | -$26.90M(-0.0%) |
| Mar 2007 | - | -$10.96M(-137.6%) | -$26.89M(-9.2%) |
| Dec 2006 | -$24.63M(-49.4%) | -$4.61M(-57.3%) | -$24.63M(-50.2%) |
| Sep 2006 | - | -$2.93M(+65.0%) | -$16.40M(+16.7%) |
| Jun 2006 | - | -$8.38M(+3.7%) | -$19.68M(-12.1%) |
| Mar 2006 | - | -$8.70M(-340.7%) | -$17.55M(-6.5%) |
| Dec 2005 | -$16.48M(+15.8%) | $3.62M(+158.2%) | -$16.48M(+21.9%) |
| Sep 2005 | - | -$6.21M(+0.6%) | -$21.12M(-14.0%) |
| Jun 2005 | - | -$6.25M(+18.2%) | -$18.52M(+1.1%) |
| Mar 2005 | - | -$7.64M(-651.9%) | -$18.71M(+4.4%) |
| Dec 2004 | -$19.57M(-52.6%) | -$1.02M(+71.9%) | -$19.57M(-5.5%) |
| Sep 2004 | - | -$3.61M(+44.0%) | -$18.55M(-24.2%) |
| Jun 2004 | - | -$6.45M(+24.1%) | -$14.94M(-75.9%) |
| Mar 2004 | - | -$8.49M | -$8.49M |
| Dec 2003 | -$12.83M(-903.8%) | - | - |
| Dec 2002 | -$1.28M | - | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of ALNY is -$8.31M
What is the all-time high annual cash from operations for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual cash from operations is $196.52M
What is Alnylam Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, ALNY annual cash from operations has changed by -$112.47M (-107.98%)
What is Alnylam Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of ALNY is $153.73M
What is the all-time high quarterly cash from operations for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly cash from operations is $359.41M
What is Alnylam Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, ALNY quarterly cash from operations has changed by +$29.57M (+23.82%)
What is Alnylam Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of ALNY is -$15.54M
What is the all-time high TTM cash from operations for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high TTM cash from operations is $372.26M
What is Alnylam Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, ALNY TTM cash from operations has changed by -$387.80M (-104.17%)